Company profile
MedMira Inc.
OTC: MMIRF · Healthcare · Biotechnology
Canadian filerHQ Halifax, NSReports USD
#1018 of 1,422 Healthcare companies by revenuebottom-quartile growth
EA Score
31DFH 28DQ —GM 27SS 58
v0.1 · 45/100 weight · provisional
↑ Piotroski F, listing tenure · ↓ balance-sheet leverage, 3-yr revenue growth
Methodology →Revenue TTM
$269.5k
Rev growth YoY (TTM)
+47.8%
Net income (FY)
-$3.2M
Employees
52
as of 2026-08-20
Market cap
$28.1M
as of 2026-08-20
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$172.4k240.5k CAD2025
Net income-$3.2M-4.5M CAD2025
Operating income-$2.6M-3.6M CAD2025
Total assets$2.7M3.7M CAD2025
Liabilities$13.7M18.9M CAD2025
Equity-$16.3M-22.6M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is MedMira Inc.’s revenue?
MedMira Inc. booked $172.4k in FY2025 revenue, contracting 43% year over year — slower than 79% of Healthcare companies we track, at a -1881.2% net margin.
Peers · Healthcare
PharmaRoth Labs, Inc.——Panacos Pharmaceuticals, Inc.——Appili Therapeutics Inc28DEden Empire Inc.——Lisata Therapeutics, Inc.39DInnerScope Hearing Technologies, Inc.——Key facts
CEOHermes Chan
SectorHealthcare
IndustryBiotechnology
HeadquartersHalifax, NS
ExchangeOTC: MMIRF
Employees52
IPO date2009-11-03
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.